企業プロフィール
Novartis AG 株価・ニュース・カタリスト
- ティッカー:
- NVS
- 取引所:
- NYSE
- セクター:
- Biopharma, Novel Therapies, Gene Therapy
- 所在地:
- Switzerland
株価パフォーマンス
151.97 USD (+0.72%)
終値
最終更新: 2026年8月17日
274B USD
時価総額
株価変動の要因
As of Aug 17, 2026, NVS closed up 0.72% at $151.97. No new same-company headline was identified in the current news window.
企業概要
事業概要
Novartis is a global medicines company with major exposure to innovative therapies across oncology, immunology, neuroscience, and cardiovascular disease. The company has been reshaping its portfolio around higher-growth, innovation-driven products.
所在地とセクター分類
Headquartered in Switzerland and listed on NYSE as an ADR, Novartis is a global biopharma with strong European and U.S. exposure. Its profile is defined by global commercial scale and a high-quality pipeline.
ビジネスモデルの特徴
Novartis generates value through branded medicines, launches, and pipeline reinvestment. Investors follow earnings quality, launch cadence, and whether the company can continue replacing mature products with growth assets.
バイオ業界での位置付け
Novartis sits among the most important global pharma names because it combines scale with consistent innovation. It is less volatile than clinical-stage biotech, but pipeline and regulatory updates can still shift the story.
今後のカタリスト
- Novartis should be tracked for Fabhalta expansion, remibrutinib progress, and any late-stage update that keeps the growth mix shifting away from older franchises. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。